Table 2.
Percentage of children under five with fever in the 2 weeks before the survey who received treatment with anti-malarial drug by country
| Country | Children with fever in the 2 weeks before the survey | Children who received ACT among those who received any anti-malarial treatment | ||||
|---|---|---|---|---|---|---|
| Received any anti-malarial | Received ACT | % (95% CI) | N | Year | ||
| % (95% CI) | % (95% CI) | N | ||||
| Angola | 28.3 (26.6–30.0) | 21.7 (20.1–23.2) | 2645 | 76.6 (73.5–79.6) | 738 | 2011 |
| Benina | 54.0 (52.5–55.5) | 0.9 (0.6–1.1) | 4204 | 1.6 (1.1–2.1) | 2243 | 2006 |
| Ethiopia | 3.6 (2.8–4.4) | 1.3 (0.8–1.8) | 2082 | 36.3 (27.8–44.9) | 124 | 2011 |
| Ghana | 43.0 (38.8–47.1) | 21.5 (18.1–24.9) | 551 | 50.0 (44.5–56.6) | 225 | 2008 |
| Kenya | 23.2 (20.9–25.4) | 7.8 (6.3–9.2) | 1385 | 33.5 (28.2–38.7) | 311 | 2009 |
| Liberia | 57.1 (54.7–59.5) | 39.7 (37.3–42.1) | 1617 | 69.6 (66.5–72.6) | 895 | 2011 |
| Madagascar | 19.8 (17.3–22.4) | 3.8 (2.6–5.0) | 959 | 19.3 (13.4–25.1) | 177 | 2011 |
| Malawi | 32.5 (29.0–36.0) | 29.6 (26.1–33.0) | 676 | 91.0 (87.1–94.8) | 216 | 2012 |
| Mali | 34.7 (31.2–38.2) | 7.8 (5.8–9.7) | 705 | 22.4 (17.1–27.6) | 243 | 2010 |
| Mozambique | 29.9 (27.4–32.4) | 17.9 (15.8–20.0) | 1313 | 59.9 (54.9–64.9) | 366 | 2011 |
| Rwanda | 10.8 (9.2–12.5) | 10.4 (8.7–12.0) | 1332 | 95.7 (92.3–99.1) | 140 | 2010 |
| Senegal | 8.2 (7.1–9.3) | 3.4 (2.6–4.1) | 2314 | 41.0 (33.7–48.3) | 176 | 2010 |
| Tanzania mainland | 60.1 (57.4–62.7) | 37.9 (35.1–40.6) | 1320 | 63.1 (59.7–66.5) | 785 | 2010 |
| Uganda | 64.5 (62.7–66.2) | 44.2 (42.4–46.1) | 2860 | 68.6 (66.5–70.7) | 1849 | 2010 |
| Zambia | 38.4 (35.4–41.3) | 11.1 (9.2–13.0) | 1034 | 29.0 (24.6–33.4) | 417 | 2007 |
| Zanzibar | 16.9 (12.5–21.3) | 5.6 (2.9–8.3) | 282 | 33.1 (18.3–48.0) | 42 | 2010 |
95 % CI 95 % confidence interval, N number of children
aArtemisinin combination therapy [ACT] was rolled out in Benin only 2 years before the survey